 |
paclitaxel-coated buttress |
|---|---|
| Trade Name | |
| Orphan Indication | For use as local administration at the time of curative surgery in the treatment of stage 0 to III non-small cell lung cancer |
| USA Market Approval | USA |
| USA Designation Date | 2014-07-15 00:00:00 |
| Sponsor | AcuityBio, Inc.;200 Upland Road;Newton, Massachusetts, 02460 |
